Spojené státy - angličtina - NLM (National Library of Medicine)

otsuka america pharmaceutical, inc. - aripiprazole (unii: 82vfr53i78) (aripiprazole - unii:82vfr53i78) - aripiprazole 2 mg - abilify (aripiprazole) oral tablets, orally-disintegrating tablets, and oral solution are indicated for the treatment of: - schizophrenia - acute treatment of manic and mixed episodes associated with bipolar i disorder - adjunctive treatment of major depressive disorder - irritability associated with autistic disorder - treatment of tourette's disorder abilify injection is indicated for the treatment of: - agitation associated with schizophrenia or bipolar mania abilify is contraindicated in patients with a history of a hypersensitivity reaction to aripiprazole. reactions have ranged from pruritus/urticaria to anaphylaxis [see adverse reactions (6.2)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to atypical antipsychotics, including abilify, during pregnancy. healthcare providers are encouraged to register patients by contacting the national pregnancy registry for atypical antipsychotics at 1-866-961-2388 or visit http://womensmentalhea

Nový Zéland - angličtina - Ministry for Primary Industries

bayer new zealand limited - triadimenol; fluopyram - suspension concentrate - triadimenol 250 g/litre; fluopyram 250 g/litre - fungicide - fungicide

Nový Zéland - angličtina - Ministry for Primary Industries

bayer new zealand limited - glyphosate - soluble concentrate - glyphosate 570 g/litre - herbicide - herbicide

Nový Zéland - angličtina - Ministry for Primary Industries

bayer new zealand limited - tebuconazole; prothioconazole - emulsifiable concentrate - tebuconazole 80 g/litre; prothioconazole 160 g/litre - fungicide - fungicide

Nový Zéland - angličtina - Ministry for Primary Industries

bayer new zealand limited - pyroxasulfone - pyroxasulfone 850 g/kg - herbicide

Nový Zéland - angličtina - myHealthbox

bayer ag - imidacloprid - suspension concentrate - imidacloprid 600 g/litre; methanol (phenylmethoxy) <> - insecticide - seedgrowth

Nový Zéland - angličtina - Ministry for Primary Industries

bayer new zealand limited - imidacloprid - imidacloprid 600 g/litre

Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

jmac (wa) pty ltd trading as pharmaust manufacturing - calamine, quantity: 50 mg/g - lotion - excipient ingredients: arachis oil; quaternium-15; calcium hydroxide; wool fat; purified water; oleic acid - this product accepted for registration/listing as 'currently supplied' at the time of commencement of the act. indications held in artg paper records. (old code) for the temporary relief of insect bites and stings

Spojené státy - angličtina - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - dexmethylphenidate hydrochloride (unii: 1678ok0e08) (dexmethylphenidate - unii:m32rh9mfgp) - dexmethylphenidate hydrochloride 2.5 mg - dexmethylphenidate hydrochloride tablets are indicated for the treatment of attention deficit hyperactivity disorder (adhd) [see clinical studies (14)]. - hypersensitivity to methylphenidate or other components of dexmethylphenidate hydrochloride tablets. hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with methylphenidate [see adverse reactions (6.1)] . - concomitant treatment with monoamine oxidase inhibitors (maois), or within 14 days following discontinuation of treatment with an moai, because of the risk of hypertensive crises [see drug interactions (7.1)] . pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to adhd medications, including dexmethylphenidate hydrochloride tablets, during pregnancy. healthcare providers are encouraged to register patients by calling the national pregnancy registry for adhd medications at 1-866-961-2388 or visit https://womensmentalhealth.org/adh

Spojené státy - angličtina - NLM (National Library of Medicine)

apotex corp. - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin 100 mg - gabapentin is indicated for: - management of postherpetic neuralgia in adults - adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy gabapentin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as gabapentin, during pregnancy. encourage women who are taking gabapentin during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry by calling the toll free number 1-888-233-2334 or visiting http:/www.aedpregnancyregistry.org/ risk summary there are no adequate data on the developmental risks associated with the use of gabapentin in pregnant women. in nonclinical studies in mice, rats, and rabbits, gabapentin was developmentally toxic (increased fetal skeletal and